Elisabetta Abruzzese

UNIVERSITY TOR VERGATA

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (21)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (19)

daniela cilloni

PROFESSOR

University of Turin

ITALY

View details

Chiara Sartor

ITALY

View details

Daniela DAMIANI

University of Udine

ITALY

View details

Monica Bocchia

University of Siena

ITALY

View details

Francesco Ferracuti

Università Politecnica delle Marche

ITALY

View details

Massimo Francalancia

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani

ITALY

View details

SIMONA SOVERINI

ASSISTANT PROFESSOR

University of Bologna

ITALY

View details

Mariella Lo Schirico

Istituto Oncologico Veneto

ITALY

View details

Florian Heidel

Professor, Director

Universitätsmedizin Greifswald

GERMANY

View details

Tim Brümmendorf

Head

University Hospital RWTH Aachen

GERMANY

View details

Simona Bernardi

University of Brescia

ITALY

View details

Daniel DeAngelo

Chief of the Division of Leukemia

Dana-Farber Cancer Institute

UNITED STATES

View details

Margherita Martelli

ITALY

View details

Antonello Di Paolo

University of Pisa

ITALY

View details

elyce cardonick

Professor

Cooper Medical School of Rowan University

UNITED STATES

View details

Jorge Cortes

Augusta University

UNITED STATES

View details

CARLO GAMBACORTI PASSERINI

Full Professor of Hematology

University of Milano-Bicocca

ITALY

View details

Giovanni Caocci

University of Cagliari

ITALY

View details

Valentin Garcia

Profesor Asociado

Universidad de Alcalá

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Elisabetta Abruzzese

Research Interests

Explore related searches

Contact this professor

Articles (21)

Treatment‐Free Remission in Chronic Phase Chronic Myeloid Leukemia After Nilotinib De‐Escalation: 96‐Week Update of the DANTE Study

How I Manage Chronic Myeloid Leukemia During Pregnancy

Treatment-Free Remission in Ph+ ALL Without Allogeneic Stem Cell Transplantation: Current Evidence and Future Directions

Dosing and clinical outcomes of ruxolitinib in patients with myelofibrosis in a real‐world setting: Interim results of the Italian observational study (ROMEI)

Therapeutic Vaccinations with p210 Peptides in Imatinib-Treated Chronic Myeloid Leukemia Patients: 10 Years Follow-Up of GIMEMA CML0206 and SI0207 Studies

Treatment strategies and survival after ruxolitinib discontinuation in myelofibrosis patients: The Italian RUX-MF multicenter study

Perspectives on Drug Development for the Treatment of Chronic Myeloid Leukemia in Pregnant Patients and Patients Who Are Breastfeeding

Correction: Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials

Efficacy and safety of bosutinib in previously treated patients with chronic myeloid leukemia: final results from the BYOND trial

Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study

Italian Physicians’ Perceptions about the Role of Asciminib in Later Lines Chronic Myeloid Leukemia in Clinical Practice: A GIMEMA Survey

Impact on mental health, disease management, and socioeconomic modifications in hematological patients during the COVID-19 pandemic in Italy

Minimal Residual Disease Detection at RNA and Leukemic Stem Cell (LSC) Levels: Comparison of RT-qPCR, d-PCR and CD26+ Stem Cell Measurements in Chronic Myeloid Leukemia (CML) Patients in Deep Molecular Response (DMR)

Peripheral blasts are associated with responses to ruxolitinib and outcomes in patients with chronic-phase myelofibrosis

Deferasirox in the management of iron overload in patients with myelofibrosis treated with ruxolitinib: The multicentre retrospective RUX‐IOL study

Chronic Myeloid Leukemia and Pregnancy: When Dreams Meet Reality. State of the Art, Management and Outcome of 41 Cases, Nilotinib Placental Transfer

COVID‐19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report

Obituary of Prof. Michele Baccarani

Next‐generation sequencing improves BCR‐ABL1 mutation detection in Philadelphia chromosome‐positive acute lymphoblastic leukaemia

The serological prevalence of SARS‐CoV‐2 infection in patients with chronic myeloid leukemia is similar to that in the general population

CD33 Expression and Gentuzumab Ozogamicin in Acute Myeloid Leukemia: Two Sides of the Same Coin

Collaborators (19)

daniela cilloni

Chiara Sartor

Daniela DAMIANI

Monica Bocchia

Francesco Ferracuti

Massimo Francalancia

SIMONA SOVERINI

Mariella Lo Schirico

Florian Heidel

Tim Brümmendorf

Simona Bernardi

Daniel DeAngelo

Margherita Martelli

Antonello Di Paolo

elyce cardonick

Jorge Cortes

CARLO GAMBACORTI PASSERINI

Giovanni Caocci

Valentin Garcia

Make your next move.